Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel HDAC inhibitors prepared and tested by 4SC and G2M scientists

March 3, 2004

Reolysin program update

March 3, 2004

Genzyme to acquire Ilex Oncology

March 3, 2004

Three series of antitumor epothilones described by GBF and Morphochem researchers

March 2, 2004

Novel proapoptotic IAP-binding agents identified at Princeton University

March 2, 2004

Lower risk for Hodgkin's lymphoma reported to be associated with aspirin use

March 2, 2004

Good pharmacological profile and antitumor activity of topoisomerase I-active agent BMS-251873

March 2, 2004

Avastin approved for first-line metastatic colorectal cancer

March 1, 2004

Abraxane enters new studies in NSCLC and metastatic melanoma

March 1, 2004

Pharmacia claims new protein kinase inhibitors for cancer and other disorders

March 1, 2004

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...